Category: Medicine

Companies aim to provide new treatments for inflammatory conditions Gilead Sciences and LEO Pharma have announced a strategic partnership to advance LEO Pharma’s oral STAT6 […]

Partnership aims to advance Alzheimer’s research with innovative tools Cambridge Cognition Holdings plc has expanded its partnership with Actinogen Medical Limited for the phase 2b/3 […]

New partnership to advance precision medicine in lung cancer diagnosis Biofidelity and CellCarta have announced a strategic partnership to utilise Biofidelity’s Aspyre® Lung in global […]

Promising results from mouse study lead to expanded trials Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for […]

Funds to accelerate commercialisation and clinical trials of diagnostic tests Owlstone Medical has announced a first close of $27 million (circa £22 million) in its […]

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to […]

First-in-human trial of PTD802 to commence following UK MHRA approval Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its […]

Companies aim to provide new treatments for inflammatory conditions Gilead Sciences and LEO Pharma have announced a strategic partnership to advance LEO Pharma’s oral STAT6 […]

Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower pharmaceutical R&D costs through efficient […]

Debra is late getting up for work again. In her heart of hearts, she’s not really enjoying her job as a teaching assistant in the […]

Groundbreaking approval provides new hope for patients in England and Wales The National Institute for Health and Care Excellence (NICE) has given a positive recommendation […]

CR-discovered NXP800 shows promise in clinical trials Prostate cancer resistant to hormone therapy could soon have a new treatment option. The Institute of Cancer Research […]

Investment to support RNA therapeutics for epilepsy and neurological disorders Angelini Ventures has co-led a €20 million Series A financing round in Neumirna Therapeutics. The […]

New FDA-approved schizophrenia treatment shows promise in clinical trials Cambridge Cognition has praised Bristol Myers Squibb for the FDA approval of Cobenfy (KarXT), a new […]

M-Trust set to improve product safety and counterfeiting solutions Merck has launched the beta version of M-Trust, a pioneering cyber-physical trust platform, at CES 2025 […]

OAV101 IT expands potential for type II SMA patients Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary […]

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional […]

EpiSwitch PSE shows promise in reducing unnecessary procedures Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch PSE, a new accurate […]

FDA gives green light to innovative device for liver conditions Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating […]

Government announces independent commission on social care The government has announced the creation of an independent commission on social care. The NHS Confederation has responded […]

MHRA urges caution over illegal medicines from beauty salons and social media The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding the public not […]

New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission has approved Rybrevant (amivantamab) […]

New CT-guided radiotherapy system offers personalised cancer treatment Berlin’s Diagnostisch Therapeutisches Zentrum (DTZ) has become the first in the world to treat a patient using […]

First patient dosed in landmark trial for GAD treatment MindMed has announced the dosing of the first patient in its phase 3 Voyage study of […]

Phase 2a study shows promising antidepressant effects Beckley Psytech has announced positive topline results from its phase 2a study of ELE-101, a synthetic intravenous (IV) […]

New treatment could revolutionise care for HAE patients Global biotechnology leader CSL has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for […]

Promising trial results support marketing authorisation application Minoryx Therapeutics and Neuraxpharm Group have announced that leriglitazone has met the primary endpoint in the NEXUS trial […]

Trial explores potential of therapy in treating multiple cancer types Bayer has begun a phase 1 clinical trial for BAY3498264, an investigational oral selective SOS1 […]

Promising results set stage for European marketing authorization Minoryx Therapeutics and Neuraxpharm Group have announced that leriglitazone met the primary endpoint in the NEXUS trial […]

Successful phase 1 study highlights potential of roginolisib iOnctura has announced promising results from the phase 1 DIONE-01 study, showcasing the clinical activity and long-term […]

New findings presented at international SCWD conference CatalYm has announced promising new data on its lead drug candidate, visugromab, at the 17th International Conference on […]

New cell therapy shows potential in treating advanced blood disorder Cellenkos has unveiled new phase 1b data for its T-regulatory cell therapy candidate, CK0804, at […]

promising pre-clinical data on preventing cytokine release syndrome Poolbeg Pharma has unveiled encouraging pre-clinical study data for POLB 001 at the 66th American Society of […]

Trial results lead to new treatment option for lung cancer AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended by NICE for treating adults […]

New antibody therapy shows promise in managing condition Neuraxpharm Group has announced that the National Institute for Health and Care Excellence (NICE) has recommended ublituximab […]

Phase 3 trial indicates significant efficacy and safety for children and adolescents Teva Pharmaceutical Industries has presented positive data from its Phase 3 SPACE study, […]

Data highlights effectiveness of EVER001 in treating pMN Everest Medicines has announced promising results from the Phase 1b/2a clinical trial of EVER001, a novel Bruton’s […]

Versant Ventures leads investment round to advance drug Antag Therapeutics has announced the closing of an €80 million Series A financing round to develop AT-7687, […]

Partnership aims to develop new radiopharmaceuticals for cancer treatment Orbit Discovery, based in Oxford, UK, and Evergreen Theragnostics, headquartered in Springfield, NJ, USA, have announced […]

Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for Health and Care Excellence (NICE) and is […]

Race to create first oral drug for obesity intensifies The competition to gain approval for the first oral GLP-1R drug for obesity is heating up, […]

New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq CLL + CNV V3 Panel, […]

Therapy for autoimmune disorder shows potential Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status by the UK Medicines and […]

Injection significantly reduces need for further treatment A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during […]

2024 ABPI Code update has launched – what’s next for pharma and QR codes? The long-anticipated update to the ABPI Code of Practice has launched, […]

Curve Therapeutics has appointed Rab Prinjha as Chief R&D Officer Curve Therapeutics has appointed Rab Prinjha as Chief Research and Development (R&D) Officer. Rab is a proven R&D leader with a […]

How industry and the NHS can work together to bridge the diagnostic gap in COPD

How oncology therapies can stand out in a diverse, uncertain landscape The oncology field is rapidly evolving, particularly with the rise of precision medicines and […]

Commit Biologics has appointed Mikkel Wandahl Pedersen as CSO Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as Chief Scientific Officer (CSO). Mikkel […]

Tessellate BIO has appointed Dr Lara Boyd as CBO Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer. Lara joins Tessellate BIO from F-star Therapeutics, […]

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution, thanks to the rapid integration […]

Mahony will continue as the UK government’s Life Sciences Investment Envoy The Department for Science, Innovation and Technology has announced that Dr Daniel Mahony will […]

The biotech will use the funding to drive sales of its first commercial product Cytomos has announced that it has raised $5m in an oversubscribed […]

The MHRA has appointed Anthony Harnden as Chair The Medicine and Healthcare products Regulatory Agency (MHRA) has appointed Anthony Harnden, Professor of Primary Care in […]

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full Good Manufacturing Practice (GMP) approval […]

The King’s Fund has appointed Siva Anandaciva as Director of Policy, Events and Partnerships The King’s Fund has appointed Siva Anandaciva, its current Chief Analyst, […]

The census found that 56% of people visit their GP for a UTI and 27% for thrush New research from PAGB has revealed that 22% […]

Somerset NHS Foundation Trust has appointed Dr Rima Makarem as Chair Somerset NHS Foundation Trust has appointed Dr Rima Makarem, who has 15 years of […]

The companies will focus on mechanisms of action, dose selection and biomarker analyses Teva Pharmaceuticals and artificial intelligence (AI)-driven Immunai have entered into a partnership […]

Therapy shows high efficacy in initial trial phase AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, […]

First participant vaccinated in study of ovx836 booster dose Osivax, a biopharmaceutical company developing vaccines for broad-spectrum protection against infectious viruses, has vaccinated the first […]

New long-term partnership to address neurological disorder treatments Vivolta, a specialist in medical electrospinning solutions, has entered a long-term partnership with UK-based Neurochase to manufacture […]

First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its […]

Insight into double-blind, phase i/ii clinical trial for oesophageal cancer Infinitopes, an integrated cancer biotech firm, will present its pioneering cancer vaccine development at the […]

Eco-friendly inhalers aim to reduce environmental impact Lupin Healthcare UK Ltd has announced plans to reformulate its pMDI inhalers with a near-zero global warming potential […]

First car t-cell therapy accepted for second-line treatment in Scotland The Scottish Medicines Consortium (SMC) has approved Kite’s CAR T-cell therapy, Yescarta (axi-cel), for treating […]

New treatment option approved for women in Scotland The Scottish Medicines Consortium (SMC) has recommended Yselty (linzagolix) for treating moderate to severe symptoms of uterine […]

New initiatives to tackle AI-related challenges in life sciences Elsevier, a leader in information and analytics, has announced its support for The Pistoia Alliance in […]

Trial to evaluate safety and efficacy of MVA-BN vaccine A new scientific trial evaluating Bavarian Nordic’s mpox vaccine in pregnant and breastfeeding women and infants […]

New therapy targets specific genetic alterations, promises extended survival Johnson & Johnson has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has […]

Phase 1 and 2 studies show promising results for anito-cel therapy Arcellx Inc, a biotechnology firm focused on cell therapy innovations, has announced impressive results […]

AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer (CEO) and member of the Board, and Magnus Ivarsson as Chief Translation and […]

Importance of continuous collaboration with rare disease communities At Blueprint Medicines, we aim to make a significant difference in patients’ lives by solving critical medical […]

Building strong partnerships with sites for more effective clinical trials When I first entered the clinical research industry more than 20 years ago, trials were […]

Walgreens Boots Alliance appoints Anthony Hemmerdinger as MD, UK and Ireland Walgreens Boots Alliance has announced the appointment of Anthony Hemmerdinger as Managing Director of Boots UK and Ireland. This […]

The new Dementia Trials Accelerator is set to receive £20m of government funding The Dementia Trials Accelerator, led by the UK Dementia Research Institute and […]

Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020 The National Institute for Health and Care Excellence (NICE) has announced […]

Approximately 8.2 million people were diagnosed with the infectious disease in 2023 The World Health Organization’s (WHO) newly published report has placed tuberculosis (TB) as […]

CAL101 shows promising results and is set to enter phase 2 development Calluna Pharma AS has announced the successful completion of Phase 1 clinical trials […]

danicopan shown to improve haemoglobin levels and reduce anaemia Alexion, AstraZeneca Rare Disease, announced that the National Institute for Health and Care Excellence (NICE) has […]

Chiesi Group has appointed Laura Vergani as SVP of Global Communications Chiesi Group has announced that Laura Vergani has joined as Senior Vice President of […]

New treatment option for patients with newly diagnosed multiple myeloma The European Commission has approved the subcutaneous (SC) formulation of DARZALEX (daratumumab) in combination with […]

Innovative Trials has appointed Ian Keith as Finance and Business Services Director Innovative Trials has appointed Ian Keith, who has been supporting the company as […]

The company’s workforce will volunteer and fundraise for Team Jak throughout the year Valneva Scotland has partnered with Team Jak, a West Lothian-headquartered charity focused […]

The five new programmes are designed to fit alongside full-time work and clinical practice Learna and the University of Wolverhampton have partnered to launch five […]

Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK The National Institute for Health and Care Excellence (NICE) […]

Phase 2 study of TG4001 shows promise in cervical cancer patients Transgene, a biotech company specializing in virus-based immunotherapies for cancer, has announced that its […]

The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics has signed a new five-year lease at White […]

The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has been launched to address the growing skills shortage in […]

NK:IO has appointed Richard Hopkins as Chief Executive Officer NK:IO has appointed Richard Hopkins, an experienced biologics developer, as its new Chief Executive Officer. Hopkins […]

There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has announced that an oral formulation of its lead […]

Partnership to harness AI for DUB-focused preclinical programmes

Study reveals potential new strategy for managing inflammatory bowel disease

Acquisition to enhance Lundbeck’s neuroscience pipeline Lundbeck has announced a significant step forward in its Focused Innovator strategy with the acquisition of Longboard Pharmaceuticals. This […]

New vaccine aims to protect older adults from severe flu complications Sanofi has announced the launch of its high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in […]

Teclistamab offers hope for patients exhausting treatment options Teclistamab (Tecvayli), a drug manufactured by Johnson & Johnson, has received a positive recommendation from NICE for […]

Sheffield cardiologists demonstrate cutting-edge TAVI procedure Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a cutting-edge heart valve replacement procedure live to an […]

New investment to advance gene therapies for kidney diseases Purespring Therapeutics has raised £80m in an oversubscribed Series B financing round. Syncona Ltd, a leading […]

AviadoBio to receive up to £1.8 billion in potential payments AviadoBio and Astellas Pharma have entered into an exclusive option and licence agreement for AVB-101, […]

Real-world studies show effectiveness of mogamulizumab in routine practice Kyowa Kirin International (KKI) has announced positive interim findings from three real-world studies on mogamulizumab (Poteligeo) […]

Scottish Medicines Consortium recommends pembrolizumab The Scottish Medicines Consortium (SMC) has recommended MSD’s KEYTRUDA (pembrolizumab) as a monotherapy for adults with non-small cell lung carcinoma […]

Biotech company moves forward with phase 2 trial for precision cancer surgery Copenhagen-based biotech company FluoGuide A/S has announced the submission of a Clinical Trial […]

£3m programme to accelerate new antimicrobial treatment Oxford Drug Design has been awarded a share of a £3 million Collaborative Discovery Programme (CDP) by the […]

New government scheme to offer routine opt-out blood tests Starting next week, Sheffield’s Northern General Hospital A&E Department will begin routine opt-out testing for HIV, […]

Harnessing vital patient data for precision in clinical trials In clinical research, leveraging patient data has become a critical factor to improve the design, execution […]

Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors Sphere Fluidics has announced the appointment of Dr Alex Dickinson to its Board of Directors as […]

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 […]

Largest real-world study demonstrates significant survival advantage In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly reduces the risk of death […]

Phase 1 trial of IRL757 demonstrates good absorption and safety profile IRLAB Therapeutics AB has announced the successful completion of the first part of its […]

Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid AlzeCure Pharma AB, a company specializing in drugs for nervous system diseases, announced […]

ISM001-055 shows promise in improving lung function among patients Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced positive preliminary results from its […]

ICON celebrates 2024 ‘company of the year’ win ICON continues to celebrate its achievement at the 2024 Clinical Researcher of the Year Awards, where we […]

The truth hurts. B2B healthcare advertising frequently misses the mark. As someone who leads a healthcare division at a creative agency, that’s hard for me […]

Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK A new study published in Nature Medicine, led by the […]

Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually A new clinical trial led by the University of Birmingham aims to […]

The progressive neurodegenerative condition affects around 153,000 people in the UK Researchers from the Universities of Nottingham and Birmingham have revealed that a new form […]

Genentech’s Pulmozyme could also treat other respiratory infections and conditions Researchers from University College London (UCL), UCL Hospital (UCLH) and the Francis Crick Institute have […]

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia Scientists from the University of Glasgow have developed the first bioengineered bone marrow […]

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide A study led by the University of Edinburgh in collaboration […]

Accreditation recognises ‘continued professional development’ opportunities As part of the Healthcare Communications Association’s partnership with this year’s PharmaTimes Communications Awards, we can now confirm that […]

The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths A study led by researchers from the Institute of […]

The most globally prevalent cancers include breast, lung, bowel and prostate cancers Researchers from Johns Hopkins Kimmel Cancer Center and its Ludwig Center, along with […]

The new technology can generate a target infection within 30 minutes to two hours Researchers from McMaster University, with support from experts at Université Laval, […]

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK King’s College London (KCL) has led the […]

Exonate has appointed Dr Rafiq Hasan as Non-Executive Director. Exonate has announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings extensive […]

Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress The National Institute for Health and Care Research (NIHR) and […]

Affecting parts of the body involving breathing, RTIs impact one in five people in England A new trial led by researchers from the University of […]

The serious, rare condition is responsible for up to 7% of all neonatal deaths globally Researchers from the University of Birmingham are developing a new […]

The progressive neurodegenerative disease affects more than 55 million people globally Innovate UK has awarded £4m through its Contracts for Innovation to four UK companies […]

The awards celebrated both medical affairs and nursing professionals in the industry The PharmaTimes Medical & Scientific Awards (MSEA) and the Nursing Industry Excellence Awards […]

Macmillan Cancer Support estimates that cancer affects over three million people in the UK A new policy review produced by cancer doctors and experts from […]

The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care Dementia researchers from the University of Liverpool have been awarded £1.5m to […]

The neurodegenerative condition currently affects more than 944,000 people in the UK University College London (UCL) and the University of Exeter are set to co-lead […]

Around one in five dementia hospitalisations are due to potentially preventable causes The UK Dementia Research Institute (UK DRI), in collaboration with the NHS, aims […]

The serious, progressive kidney disease affects nearly 850 million people worldwide The Scottish Medicines Consortium (SMC) has accepted Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin) […]

Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer The Francis Crick Institute and Imperial College London (ICL) cancer therapy spinout, Myricx Bio, […]

The progressive neurodegenerative condition affects around 153,000 people in the UK Mission Therapeutics has been awarded $5.2m in funding from Parkinson’s UK’s Virtual Biotech programme […]

More than 176,000 people in the UK are living with a stoma, according to NHS data Coloplast has announced the launch of its world-first digital […]

Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children Researchers from the Wellcome Sanger Institute, […]

Frontier Science Scotland appoints Prof Bjoern Schelter as a Director to its Board of Trustees Frontier Science Scotland has announced the appointment of Professor Bjoern Schelter as a new Director […]

The neurodegenerative disease currently affects more than 200,000 people worldwide NeuroSense Therapeutics has announced positive mid-stage results of its lead drug candidate, PrimeC, in people […]

Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide A study, published in Nature, has revealed a new way to map the spread […]

The progressive neurological condition affects around 153,000 people in the UK Herantis Pharma has been awarded €3.6m in funding from Parkinson’s UK’s Virtual Biotech programme […]

Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses Scientists from the Institute of Cancer Research (ICR) have revealed new inherited […]

Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally A study led by researchers at King’s College London (KCL) […]

Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK Researchers from University College London (UCL) have revealed that cardiovascular health could […]

Kronos Bio has appointed Deborah Knobelman as Chief Operating Officer Kronos Bio has appointed Deborah Knobelman as Chief Operating Officer and Chief Financial Officer. She will oversee the finance, accounting, business […]

As research advances, allowing scientists to more clearly pinpoint the underlying causes of disease, new drugs are becoming more precise and highly targeted. At the […]

The challenge of continuously raising prostate cancer awareness

Weight loss drugs are the word on the street and it’s getting serious With all the noise surrounding ‘miracle’ weight loss drugs recently, it is […]

The neurodegenerative condition currently affects around 153,000 people in the UK Parkinson’s UK has awarded nearly £100,000 to researchers at Imperial College London (ICL) to […]

The study found an increase in incidence among young people and people from deprived areas A study conducted by European researchers from the University of […]

Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy A new study sponsored by University College London (UCL) has begun, making it […]

Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK A new collaboration between Newcastle University, the Wellcome Sanger Institute (Sanger) and […]

AD is the most common form of dementia, which affects over 944,000 people in the UK Researchers from the University of Sheffield’s Institute of Translational […]

The initiative’s proposals aim to tackle current challenges in health research and innovation The Innovative Health Initiative (IHI) has launched a new call for proposals, […]

An estimated 27% of patients globally living with diabetes will be affected by retinopathy A study conducted by Oxford Population Health has demonstrated that a […]

Atherosclerotic plaques in the arteries affect 42% of adults living without heart disease Researchers from the University of Bristol have revealed a new disease-driving mechanism […]

The initiative aims to improve African pandemics, outbreaks, preparedness and responses The EU, its Member States and European financial institutions have announced a more than […]

The manifesto calls on the next UK government to make dementia a key health priority Alzheimer’s Society, Dementia UK, Alzheimer’s Research UK, the UK Dementia […]

According to WHO, cardiovascular diseases are responsible for 17.9 million annual deaths Researchers from Innsbruck Medical University, Austria, have developed a new treatment that could […]

The method provides a more accurate and ethical approach to drug testing for medicines Researchers from King’s College London (KCL) have created a mini lab-grown […]

The lifelong inflammatory bowel disease affects around one in every 350 people in the UK Researchers from the University of Cambridge have grown ‘mini-guts’ in […]

The progressive neurodegenerative condition affects more than ten million people worldwide Researchers from Johns Hopkins Medicine have revealed that a cancer drug could be used […]

The serious condition is responsible for approximately 11 million deaths worldwide every year Researchers from the Wellcome Sanger Institute, the University of Oxford and collaborators […]

Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children Researchers from the Francis Crick Institute, University College London (UCL) Great […]

Stroke causes over seven million new cases annually, ranking second in leading global mortality Researchers from King’s College London (KCL) and the University of Helsinki, […]

The progressive neurological disorder currently affects more than 200,000 people worldwide The University Medical Center (UMC) Utrecht, Netherlands, has announced that it has enrolled its […]

Medulloblastoma is responsible for around 52 new cases in children in the UK every year A new study led by Newcastle University and the University […]

Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020 Leuko, founded by researchers at the Massachusetts Institute of Technology […]

The mosquito-borne viral disease is responsible for an estimated 390 million cases globally LifeArc has announced that it will be funding three new projects to […]

The installation will double the capacity of cancer genomic testing using robotic automation The Royal Marsden NHS Foundation Trust has launched the UK’s first ever […]

NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients Researchers at the Francis Crick Institute, University College London (UCL) and […]

AMR is designated as one of the top ten global public health threats facing humanity by WHO Sysmex Astrego AB, a subsidiary of Sysmex Corporation, […]

Technology is key to recruiting and retaining clinical trial participants

The donation will help scientists and clinicians collaborate and make new advances in research Imperial College London (ICL) has received a £10m donation from the […]

Two support cells, microglia and astrocytes, were found to communicate with each other Researchers at the Francis Crick Institute, University College London’s UK Dementia Research […]

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally Lucy Therapeutics (LucyTx) has announced it has raised $12.5m in additional funding […]

The leading cause of cancer globally accounts for an estimated 1.8 million deaths annually Researchers from the Johns Hopkins Kimmel Cancer Center and other institutions […]

Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the UK The Dana-Farber Cancer Institute and OncoHost […]

Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK Researchers from University College London (UCL) and Great Ormond Street […]

What can pharma do to proactively take on climate change?

Phase 2 trial reveals significant improvement in MASH patients Boehringer Ingelheim has unveiled promising results from a Phase II trial of survodutide, demonstrating a notable […]

Early-stage endometriosis now visible through non-invasive imaging In a significant advancement for endometriosis diagnosis, Serac Healthcare, in collaboration with the University of Oxford, has presented […]

Innovative antibody discovery could lead to new Parkinson’s treatments Cambridge-based Alchemab Therapeutics has been awarded a substantial grant from The Michael J. Fox Foundation to […]

Inebilizumab shows sound efficacy in landmark research Amgen has announced a breakthrough in the treatment of Immunoglobulin G4-related disease (IgG4-RD) with its phase 3 clinical […]

Extended phase 2 study highlights macrophage cell therapy’s efficacy Resolution Therapeutics Limited, in collaboration with the University of Edinburgh, has presented compelling clinical data at […]

Phase 3 research suggests a significant leap forward in myeloma management Sanofi’s Sarclisa, a novel treatment for multiple myeloma, has demonstrated a substantial improvement in […]

Positive clinical data from phase 1 study presented at ASCO annual meeting invoX Pharma Limited has presented updated findings from its phase 1 study of […]

Collaboration yields promising Barriolide therapy Enterothelin EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company, and AlveoliX, an innovator in organ-on-chip technology, have announced significant advancements in their […]

The platform will be used to diagnose and treat cancers, including lung and brain tumours A new international study led by King’s College London (KCL) […]

Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy A new type of immunotherapy developed by researchers from […]

The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines The NHS has announced that it has treated its first […]

The projects will focus on a range of research areas, including Down’s syndrome and ALS The Francis Crick Institute has announced six new partnerships with […]

Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns A new study led by Newcastle University […]

The first phase of the programme will be in place in hospitals across the UK by March 2025 The NHS has announced the roll out […]

The proposals will help MedTech developers access NHS funding to fast-track products NHS England and the National Institute for Health and Care Excellence (NICE) have […]

Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation The British Heart Foundation (BHF) has […]

The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029 The Medical Research Council (MRC) […]